These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 26546158

  • 1. Genome-wide studies identify a novel interplay between AML1 and AML1/ETO in t(8;21) acute myeloid leukemia.
    Li Y, Wang H, Wang X, Jin W, Tan Y, Fang H, Chen S, Chen Z, Wang K.
    Blood; 2016 Jan 14; 127(2):233-42. PubMed ID: 26546158
    [Abstract] [Full Text] [Related]

  • 2. Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells.
    Trombly DJ, Whitfield TW, Padmanabhan S, Gordon JA, Lian JB, van Wijnen AJ, Zaidi SK, Stein JL, Stein GS.
    BMC Genomics; 2015 Apr 17; 16(1):309. PubMed ID: 25928846
    [Abstract] [Full Text] [Related]

  • 3. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.
    Mandoli A, Singh AA, Prange KHM, Tijchon E, Oerlemans M, Dirks R, Ter Huurne M, Wierenga ATJ, Janssen-Megens EM, Berentsen K, Sharifi N, Kim B, Matarese F, Nguyen LN, Hubner NC, Rao NA, van den Akker E, Altucci L, Vellenga E, Stunnenberg HG, Martens JHA.
    Cell Rep; 2016 Nov 15; 17(8):2087-2100. PubMed ID: 27851970
    [Abstract] [Full Text] [Related]

  • 4. AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia.
    Dunne J, Gascoyne DM, Lister TA, Brady HJ, Heidenreich O, Young BD.
    Cancer Res; 2010 May 15; 70(10):3985-95. PubMed ID: 20460523
    [Abstract] [Full Text] [Related]

  • 5. UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.
    Goyama S, Schibler J, Gasilina A, Shrestha M, Lin S, Link KA, Chen J, Whitman SP, Bloomfield CD, Nicolet D, Assi SA, Ptasinska A, Heidenreich O, Bonifer C, Kitamura T, Nassar NN, Mulloy JC.
    Leukemia; 2016 Mar 15; 30(3):728-39. PubMed ID: 26449661
    [Abstract] [Full Text] [Related]

  • 6. Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway.
    Li Y, Gao L, Luo X, Wang L, Gao X, Wang W, Sun J, Dou L, Li J, Xu C, Wang L, Zhou M, Jiang M, Zhou J, Caligiuri MA, Nervi C, Bloomfield CD, Marcucci G, Yu L.
    Blood; 2013 Jan 17; 121(3):499-509. PubMed ID: 23223432
    [Abstract] [Full Text] [Related]

  • 7. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
    Elsässer A, Franzen M, Kohlmann A, Weisser M, Schnittger S, Schoch C, Reddy VA, Burel S, Zhang DE, Ueffing M, Tenen DG, Hiddemann W, Behre G.
    Oncogene; 2003 Aug 28; 22(36):5646-57. PubMed ID: 12944913
    [Abstract] [Full Text] [Related]

  • 8. The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes.
    Bakshi R, Zaidi SK, Pande S, Hassan MQ, Young DW, Montecino M, Lian JB, van Wijnen AJ, Stein JL, Stein GS.
    J Cell Sci; 2008 Dec 01; 121(Pt 23):3981-90. PubMed ID: 19001502
    [Abstract] [Full Text] [Related]

  • 9. An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells.
    Zaidi SK, Perez AW, White ES, Lian JB, Stein JL, Stein GS.
    Oncotarget; 2017 Jun 20; 8(25):39994-40005. PubMed ID: 28611288
    [Abstract] [Full Text] [Related]

  • 10. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.
    Vangala RK, Heiss-Neumann MS, Rangatia JS, Singh SM, Schoch C, Tenen DG, Hiddemann W, Behre G.
    Blood; 2003 Jan 01; 101(1):270-7. PubMed ID: 12393465
    [Abstract] [Full Text] [Related]

  • 11. Histone deacetylase 3 preferentially binds and collaborates with the transcription factor RUNX1 to repress AML1-ETO-dependent transcription in t(8;21) AML.
    Guo C, Li J, Steinauer N, Wong M, Wu B, Dickson A, Kalkum M, Zhang J.
    J Biol Chem; 2020 Mar 27; 295(13):4212-4223. PubMed ID: 32071087
    [Abstract] [Full Text] [Related]

  • 12. Pontin is a critical regulator for AML1-ETO-induced leukemia.
    Breig O, Bras S, Martinez Soria N, Osman D, Heidenreich O, Haenlin M, Waltzer L.
    Leukemia; 2014 Jun 27; 28(6):1271-9. PubMed ID: 24342949
    [Abstract] [Full Text] [Related]

  • 13. AML1/ETO trans-activates c-KIT expression through the long range interaction between promoter and intronic enhancer.
    Tian Y, Wang G, Hu Q, Xiao X, Chen S.
    J Cell Biochem; 2018 Apr 27; 119(4):3706-3715. PubMed ID: 29236325
    [Abstract] [Full Text] [Related]

  • 14. Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia.
    Huang S, Jiang MM, Chen GF, Qian K, Gao HH, Guan W, Shi JL, Liu AQ, Liu J, Wang BH, Li YH, Yu L.
    Chin Med J (Engl); 2016 Jun 05; 129(11):1355-62. PubMed ID: 27231175
    [Abstract] [Full Text] [Related]

  • 15. Disruption of the NHR4 domain structure in AML1-ETO abrogates SON binding and promotes leukemogenesis.
    Ahn EY, Yan M, Malakhova OA, Lo MC, Boyapati A, Ommen HB, Hines R, Hokland P, Zhang DE.
    Proc Natl Acad Sci U S A; 2008 Nov 04; 105(44):17103-8. PubMed ID: 18952841
    [Abstract] [Full Text] [Related]

  • 16. RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.
    Ptasinska A, Pickin A, Assi SA, Chin PS, Ames L, Avellino R, Gröschel S, Delwel R, Cockerill PN, Osborne CS, Bonifer C.
    Cell Rep; 2019 Sep 17; 28(12):3022-3031.e7. PubMed ID: 31533028
    [Abstract] [Full Text] [Related]

  • 17. Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding.
    Ptasinska A, Assi SA, Mannari D, James SR, Williamson D, Dunne J, Hoogenkamp M, Wu M, Care M, McNeill H, Cauchy P, Cullen M, Tooze RM, Tenen DG, Young BD, Cockerill PN, Westhead DR, Heidenreich O, Bonifer C.
    Leukemia; 2012 Aug 17; 26(8):1829-41. PubMed ID: 22343733
    [Abstract] [Full Text] [Related]

  • 18. Epigenetic silencing of miR564 contributes to the leukemogenesis of t(8;21) acute myeloid leukemia.
    Yang E, Guan W, Gong D, Gao X, Han C, Zhang J, Wang H, Wang M, Li Y, Yu L.
    Clin Sci (Lond); 2020 Dec 11; 134(23):3079-3091. PubMed ID: 33201243
    [Abstract] [Full Text] [Related]

  • 19. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S, Klisovic RB, Vukosavljevic T, Yu J, Paschka P, Huynh L, Pang J, Neviani P, Liu Z, Blum W, Chan KK, Perrotti D, Marcucci G.
    J Pharmacol Exp Ther; 2007 Jun 11; 321(3):953-60. PubMed ID: 17389244
    [Abstract] [Full Text] [Related]

  • 20. MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML.
    Vegi NM, Klappacher J, Oswald F, Mulaw MA, Mandoli A, Thiel VN, Bamezai S, Feder K, Martens JHA, Rawat VPS, Mandal T, Quintanilla-Martinez L, Spiekermann K, Hiddemann W, Döhner K, Döhner H, Stunnenberg HG, Feuring-Buske M, Buske C.
    Cell Rep; 2016 Jul 12; 16(2):498-507. PubMed ID: 27346355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.